FibroBiologics, Inc. Public Float
FibroBiologics, Inc. (FBLG) had Public Float of $21.60 million as of 2025-06-30, per its 10-K/A filed 2026-03-13.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-13
- 2025-06-30: Entity Public Float $21.60M.
- 2024-06-28: Entity Public Float $147.40M.
- 2023-06-30: Entity Public Float $0.00.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $21.60M 10-K/A · filed 2026-03-13 |
| 2024-06-28 | $147.40M 10-K · filed 2025-03-31 |
| 2023-06-30 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |